146 related articles for article (PubMed ID: 21984931)
1. Genetic variants in TGF-β pathway are associated with ovarian cancer risk.
Yin J; Lu K; Lin J; Wu L; Hildebrandt MA; Chang DW; Meyer L; Wu X; Liang D
PLoS One; 2011; 6(9):e25559. PubMed ID: 21984931
[TBL] [Abstract][Full Text] [Related]
2. SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.
Li Q; Wu H; Chen B; Hu G; Huang L; Qin K; Chen Y; Yuan X; Liao Z
PLoS One; 2012; 7(12):e51713. PubMed ID: 23284751
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.
Wei H; Kamat AM; Aldousari S; Ye Y; Huang M; Dinney CP; Wu X
PLoS One; 2012; 7(12):e51758. PubMed ID: 23251617
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
6. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
7. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
Xie H; Tao W; Wu X; Gu J
Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.
Meng QH; Xu E; Hildebrandt MA; Liang D; Lu K; Ye Y; Wagar EA; Wu X
Clin Chem; 2014 Jan; 60(1):222-32. PubMed ID: 24146310
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.
Shimizu C; Jain S; Davila S; Hibberd ML; Lin KO; Molkara D; Frazer JR; Sun S; Baker AL; Newburger JW; Rowley AH; Shulman ST; Burgner D; Breunis WB; Kuijpers TW; Wright VJ; Levin M; Eleftherohorinou H; Coin L; Popper SJ; Relman DA; Fury W; Lin C; Mellis S; Tremoulet AH; Burns JC
Circ Cardiovasc Genet; 2011 Feb; 4(1):16-25. PubMed ID: 21127203
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
Sun Y; Tao W; Huang M; Wu X; Gu J
J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
[TBL] [Abstract][Full Text] [Related]
12. A Single-Nucleotide Polymorphism (rs1131243) of the Transforming Growth Factor Beta Signaling Pathway Contributes to Risk of Acute Rejection in Chinese Renal Transplant Recipients.
Zheng M; Yang H; Li W; Zhou J; Wei J; Wang Z; Guo M; Chen H; Sun L; Han Z; Tao J; Ju X; Tan R; Wei J; Gu M
Med Sci Monit; 2019 Dec; 25():9138-9158. PubMed ID: 31786580
[TBL] [Abstract][Full Text] [Related]
13. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.
Lin M; Stewart DJ; Spitz MR; Hildebrandt MA; Lu C; Lin J; Gu J; Huang M; Lippman SM; Wu X
Carcinogenesis; 2011 Jul; 32(7):1050-6. PubMed ID: 21515830
[TBL] [Abstract][Full Text] [Related]
16. A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population.
Li J; Zou L; Zhou Y; Li L; Zhu Y; Yang Y; Gong Y; Lou J; Ke J; Zhang Y; Tian J; Zou D; Peng X; Chang J; Gong J; Zhong R; Zhou X; Miao X
Mol Carcinog; 2017 Jul; 56(7):1798-1807. PubMed ID: 28218435
[TBL] [Abstract][Full Text] [Related]
17. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
18. Stepwise approach to SNP-set analysis illustrated with the Metabochip and colorectal cancer in Japanese Americans of the Multiethnic Cohort.
Cologne J; Loo L; Shvetsov YB; Misumi M; Lin P; Haiman CA; Wilkens LR; Le Marchand L
BMC Genomics; 2018 Jul; 19(1):524. PubMed ID: 29986644
[TBL] [Abstract][Full Text] [Related]
19. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway.
Dimitriou R; Carr IM; West RM; Markham AF; Giannoudis PV
BMC Musculoskelet Disord; 2011 Feb; 12():44. PubMed ID: 21310029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
